Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Chan

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Progress in Molecular Biology and Translational Science|June 2, 2020
Microbiome and cancer treatment: Are we ready to apply in clinics?Stephen L Chan
Journal of Gastroenterology and Hepatology|February 29, 2012
Targeted therapy of hepatocellular carcinoma: present and futureStephen L Chan, Winnie Yeo
World Journal of Gastroenterology|April 4, 2014
Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insightsStephen L Chan, Winnie Yeo
Cancers|March 25, 2022
Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular CarcinomaLandon L Chan, Stephen L Chan
Therapeutic Advances in Medical Oncology|March 27, 2025
Future perspectives on immunotherapy for hepatocellular carcinomaLandon L Chan, Stephen L Chan
Expert Opinion on Therapeutic Targets|February 9, 2012
Novel systemic therapeutic for nasopharyngeal carcinomaStephen L Chan, Brigette B Ma
Expert Opinion on Drug Metabolism & Toxicology|October 16, 2014
An update on the safety and efficacy of regorafenib in the treatment of solid cancersStephen L Chan, Brigette By Ma
Expert Opinion on Emerging Drugs|March 16, 2021
Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinomaLandon L Chan, Stephen L Chan
Clinical and Molecular Hepatology|May 25, 2023
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatmentLandon L Chan, Stephen L Chan
Liver Cancer|April 19, 2024
Recent Advances in Systemic Therapy for Advanced Intrahepatic CholangiocarcinomaChanghoon Yoo, Jaewon Hyung, Stephen L Chan
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Progress in Molecular Biology and Translational Science|June 2, 2020
Microbiome and cancer treatment: Are we ready to apply in clinics?Stephen L Chan
Journal of Gastroenterology and Hepatology|February 29, 2012
Targeted therapy of hepatocellular carcinoma: present and futureStephen L Chan, Winnie Yeo
World Journal of Gastroenterology|April 4, 2014
Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insightsStephen L Chan, Winnie Yeo
Cancers|March 25, 2022
Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular CarcinomaLandon L Chan, Stephen L Chan
Therapeutic Advances in Medical Oncology|March 27, 2025
Future perspectives on immunotherapy for hepatocellular carcinomaLandon L Chan, Stephen L Chan
Expert Opinion on Therapeutic Targets|February 9, 2012
Novel systemic therapeutic for nasopharyngeal carcinomaStephen L Chan, Brigette B Ma
Expert Opinion on Drug Metabolism & Toxicology|October 16, 2014
An update on the safety and efficacy of regorafenib in the treatment of solid cancersStephen L Chan, Brigette By Ma
Expert Opinion on Emerging Drugs|March 16, 2021
Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinomaLandon L Chan, Stephen L Chan
Clinical and Molecular Hepatology|May 25, 2023
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatmentLandon L Chan, Stephen L Chan
Liver Cancer|April 19, 2024
Recent Advances in Systemic Therapy for Advanced Intrahepatic CholangiocarcinomaChanghoon Yoo, Jaewon Hyung, Stephen L Chan
Pageof 17